Anil Potti and his colleagues have retracted another paper, “Characterizing the Clinical Relevance of an Embryonic Stem Cell Phenotype in Lung Adenocarcinoma,” originally published in the December 15, 2009, issue of Clinical Cancer Research. According to the notice:
A 60 Minutes segment Sunday on Anil Potti has drawn national attention to the case, so we thought this would be a good time to compile all of the retractions and corrections in one place. Duke has said that about a third of Potti’s 40-some-odd papers would be retracted, and another third would have “a … Continue reading The Anil Potti retraction record so far
The authors of a paper in the Journal of Biological Chemistry (JBC) have retracted it, but don’t ask us why. This being the JBC, the retraction notice for “Human T-cell Leukemia Virus Type I Tax Down-regulates the Expression of Phosphatidylinositol 3,4,5-Trisphosphate Inositol Phosphatases via the NF-κB Pathway” is the very definition of opaque:
Alirio Melendez, whose former employer, the National University of Singapore, is investigating about 70 of his papers, has retracted a second study. Here’s the notice for the 2010 Journal of Molecular Cell Biology paper, “Sphingosine-1-phosphate mediates proliferation maintaining the multipotency of human Adult Bone Marrow and Adipose Tissue-derived Stem Cells:”
Like many researchers, Frank Walboomers frequently checks the scientific databases to see when his latest publications appear. He was doing so a few months ago when he came across his name on an article — “Effects of pro-inflammatory cytokines on mineralization potential of rat dental pulp stem cells” — published online in July in the … Continue reading “Ill communication” leads to retraction of tissue paper (sorry) for authorship issues
The Korean Journal of Otolaryngology-Head and Neck Surgery has retracted 17 papers, with the common theme of ‘overlap’ — almost always a euphemism for plagiarism, whether self or otherwise. Published between 1993 and 2006, the articles came from a group of authors at the department of otolaryngology at Ajou University School of Medicine in Suwon, … Continue reading Korean ENT journal retracts 17 papers, citing ‘overlap’
2010 was a busy year at Retraction Watch. (Well, actually the first seven months of it weren’t busy at all, since we didn’t launch until August.) We’ve published 88 posts, an average of about four per week. We no longer wonder whether we’ll have enough material to post frequently, as Adam told The New York … Continue reading Top Retraction Watch posts of 2010, and a short wish list for 2011
Last week, we noted a Nature editorial in which the journal came clean about its higher-than-average number of retractions this year — four. What we missed was the fact that the fourth retraction of the year also appeared in last week’s issue. The retraction, of a paper called “The large-conductance Ca2+-activated K+ channel is essential … Continue reading Previously questioned Nature paper on innate immunity retracted
This week’s Nature includes a refreshing and soul-searching editorial about retractions. Excerpt (we added links and corrected a misspelling and wrong country in the editorial after a reader noted the errors below): This year, Nature has published four retractions, an unusually large number. In 2009 we published one. Throughout the past decade, we have averaged … Continue reading Nature comes clean about retractions and why they’re on the rise
A day after an up and coming Harvard stem cell scientist retracted a Nature paper, Blood has issued a notice of concern about another paper by the same group, published in August 2008, the Boston Globe reports. Such notices often, but not always, precede retractions. According to the notice for “Osteolineage niche cells initiate hematopoietic … Continue reading Blood posts “notice of concern” over second Wagers-Mayack paper